Why Do Specialty Drugs Have Different Cost-Sharing Than Regular Prescriptions?
Most prescriptions come with a predictable copay, but specialty medications tend to break that pattern entirely, and the reason comes down to how their cost-sharing is structured in the first place.
The short answer
Specialty drugs — often complex biologics, injectables, or infused medications used for chronic or serious conditions — are frequently billed as coinsurance, a percentage of the drug’s price, rather than a flat copay. Because these medications can be far more expensive than a typical brand-name prescription, even a modest coinsurance percentage can translate into a large dollar amount for a single fill.
Why plans use coinsurance instead of a flat fee
A flat copay works reasonably well when a drug’s price is fairly stable and predictable, which is generally true of generics and many standard brand-name drugs, the kind covered when copay, coinsurance, and out-of-pocket max are explained in general terms. Specialty medications don’t fit that pattern — their prices can be dramatically higher and vary more between products, so a plan sets cost-sharing as a percentage rather than picking one dollar figure that might badly undercharge for an expensive drug or overcharge for a comparatively cheaper one. This connects back to how drug formularies assign tiers in the first place, since specialty medications almost always sit in the highest cost-sharing tier.
How this can create large out-of-pocket exposure
Because coinsurance scales with price, a specialty drug that costs many times more than a standard brand-name medication can leave a person owing a correspondingly larger share, even under the same percentage. This is one reason specialty tier costs are often the fastest way a person’s spending reaches their plan’s out-of-pocket maximum for the year — once that limit is hit, the plan generally covers 100% of covered costs for the remainder of the plan year, though the details depend on the specific policy.
The deductible often applies first
Many plans require the plan’s deductible to be met before specialty coinsurance even kicks in, which can front-load a large expense early in the year, particularly for someone newly prescribed a specialty medication or filling one for the first time after a plan renewal.
What can help offset the cost
- Manufacturer assistance programs. Some drug manufacturers offer programs that reduce what a patient owes for a specific specialty medication, though eligibility rules and program availability vary and can change.
- Specialty pharmacy requirements. Many plans require specialty drugs to be filled through a designated specialty pharmacy, which sometimes comes with additional support services like coordination of refills and side-effect monitoring.
- Prior authorization. Specialty medications often require prior authorization, meaning the prescriber must document medical necessity before the plan will cover it at all.
- Formulary exceptions. If a lower-cost alternative exists but isn’t appropriate for a specific medical situation, a formulary exception request can sometimes shift coverage, similar to the process used for other tiered prescriptions.
Why this structure isn’t going away
Specialty medications represent a small share of total prescriptions but an outsized share of total drug spending, which is part of why insurers have been reluctant to move away from percentage-based cost-sharing for this category. The structure shifts more of the cost variability onto the person filling the prescription, which makes understanding the underlying mechanics — rather than assuming a specialty drug will cost roughly what a regular prescription does — genuinely useful before a fill is due.
A practical habit
Before starting a specialty medication, checking the plan’s specific coinsurance percentage, confirming whether the deductible has been met, and asking about manufacturer or foundation assistance programs can turn an unpredictable number into a much clearer one. None of these figures are standard across plans, so the plan’s own documents and pharmacy benefit information remain the most reliable source.